Cargando…
The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SEPAR. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474890/ https://www.ncbi.nlm.nih.gov/pubmed/34629674 http://dx.doi.org/10.1016/j.arbres.2020.07.038 |
| _version_ | 1783579410834653184 |
|---|---|
| author | Cillóniz, Catia Torres, Antoni Garcia-Vidal, Carolina Moreno-Garcia, Estela Amaro, Rosanel Soler, Nestor Marcos, M. Angeles Rico, Verónica Gabarrús, Albert Nicolás, Josep María Soriano, Alex |
| author_facet | Cillóniz, Catia Torres, Antoni Garcia-Vidal, Carolina Moreno-Garcia, Estela Amaro, Rosanel Soler, Nestor Marcos, M. Angeles Rico, Verónica Gabarrús, Albert Nicolás, Josep María Soriano, Alex |
| author_sort | Cillóniz, Catia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7474890 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | SEPAR. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74748902020-09-08 The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia Cillóniz, Catia Torres, Antoni Garcia-Vidal, Carolina Moreno-Garcia, Estela Amaro, Rosanel Soler, Nestor Marcos, M. Angeles Rico, Verónica Gabarrús, Albert Nicolás, Josep María Soriano, Alex Arch Bronconeumol Scientific Letter SEPAR. Published by Elsevier España, S.L.U. 2021-01 2020-09-06 /pmc/articles/PMC7474890/ /pubmed/34629674 http://dx.doi.org/10.1016/j.arbres.2020.07.038 Text en © 2020 SEPAR. Published by Elsevier España, S.L.U. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Scientific Letter Cillóniz, Catia Torres, Antoni Garcia-Vidal, Carolina Moreno-Garcia, Estela Amaro, Rosanel Soler, Nestor Marcos, M. Angeles Rico, Verónica Gabarrús, Albert Nicolás, Josep María Soriano, Alex The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title | The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title_full | The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title_fullStr | The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title_full_unstemmed | The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title_short | The Value of C-Reactive Protein-to-Lymphocyte Ratio in Predicting the Severity of SARS-CoV-2 Pneumonia |
| title_sort | value of c-reactive protein-to-lymphocyte ratio in predicting the severity of sars-cov-2 pneumonia |
| topic | Scientific Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7474890/ https://www.ncbi.nlm.nih.gov/pubmed/34629674 http://dx.doi.org/10.1016/j.arbres.2020.07.038 |
| work_keys_str_mv | AT cillonizcatia thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT torresantoni thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT garciavidalcarolina thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT morenogarciaestela thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT amarorosanel thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT solernestor thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT marcosmangeles thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT ricoveronica thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT gabarrusalbert thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT nicolasjosepmaria thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT sorianoalex thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT thevalueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT cillonizcatia valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT torresantoni valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT garciavidalcarolina valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT morenogarciaestela valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT amarorosanel valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT solernestor valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT marcosmangeles valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT ricoveronica valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT gabarrusalbert valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT nicolasjosepmaria valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT sorianoalex valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia AT valueofcreactiveproteintolymphocyteratioinpredictingtheseverityofsarscov2pneumonia |